Clinical Trial Update: Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation (DIAN-TU) [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for the DIAN-TU study, investigating disease-modifying therapies in individuals with dominantly inherited early-onset Alzheimer's disease;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Alzheimer Disease Familial
• Dementia

Drugs mentioned

• Gantenerumab (gantenerumab)
• Solanezumab (solanezumab)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Alzheimers Disease, Dementia | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING